Glutathione S-transferase π1 promotes tumorigenicity in HCT116 human colon cancer cells

Cancer Research

Volumn 65, Issue 20, 2005, Pages 9485-9494

  Dang, Duyen T ^a,b   Chen, Fang ^a   Kohli, Manu ^c   Rago, Carlo ^c   Cummins, Jordan M ^c   Dang, Long H ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GLUTATHIONE S TRANSFERASE PI1; GLUTATHIONE TRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER RISK; CARCINOGENICITY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL SURVIVAL; CLONOGENIC ASSAY; COLON CARCINOGENESIS; COLORECTAL CANCER; CONJUGATION; CONTROLLED STUDY; DETOXIFICATION; ENZYME MECHANISM; FEMALE; GENE; GENE DISRUPTION; GENE LOSS; GENE OVEREXPRESSION; GENE TARGETING; GSTP1 GENE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FAMILY;

ANIMALS; APOPTOSIS; CELL GROWTH PROCESSES; COLONIC NEOPLASMS; FEMALE; G1 PHASE; GLUTATHIONE S-TRANSFERASE PI; HCT116 CELLS; HT29 CELLS; HUMANS; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OXIDATIVE STRESS; RECOMBINATION, GENETIC; S PHASE;

EID: 27144492939     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-1930     Document Type: Article

References (68)

1. Moscow JA, Fairchild CR, Madden MJ, et al. Expression of anionic glutathione-5-transferase and P-glycoprotein genes in human tissues and tumors. Cancer Res 1989;49:1422-8.
2. Sato K. Glutathione transferases as markers of preneoplasia and neoplasia. Adv Cancer Res 1989;52:205-55.
3. Howie AF, Forrester LM, Glancey MJ, et al. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis 1990;11:451-8.
4. Ranganathan S, Tew KD. Immunohistochemical localization of glutathione S-transferases α, μ, and π in normal tissue and carcinomas from human colon. Carcinogenesis 1991;12:2383-7.
5. Ali-Osman F, Branner JM, Kutluk TM, Hess K. Prognostic significance of glutathione S-transferase π expression and subcellular localization in human gliomas. Clin Cancer Res 1997;3:2253-61.
6. Miyanishi K, Takayama T, Ohi M, et al. Glutathione S-transferase-π overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology 2001;121:865-74.
7. Lee WH, Morton RA, Epstein JI, et al. Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci U S A 1994;91:11733-7.
8. Cotton SC, Sharp L, Little J, Brockton N. Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol 2000;151:7-32.
9. Tew KD, Dutta S, Schultz M. Inhibitors of glutathione S-transferases as therapeutic agents. Adv Drug Deliv Rev 1997;26:91-104.
10. Kinzler KW, Vogelstein B. Lessons from hereditary colon cancer. Cell 1996;87:159-70.
11. Clapper ML, Hoffman SJ, Carp N, et al. Contribution of patient history to the glutathione S-transferase activity of human lung, breast and colon tissue. Carcinogenesis 1991;12:1957-61.
12. Clapper ML, Hoffman SJ, Tew KD. Glutathione S-transferases in normal and malignant human colon tissue. Biochim Biophys Acta 1991;1096:209-16.
13. Morse MA. The roie of glutathione S-transferase P1-1 in colorectal cancer: friend or foe? Gastroenterology 2001;121:1010-3.
14. Tew KD, Ronai Z. GST function in drug and stress response. Drug Resist Updat 1999;2:143-7.
15. Boyland E, Chasseaud LF. The role of glutathione and glutathione S-transferases in mercapturic acid biosynthesis. Adv Enzymol Relat Areas Mol Biol 1969;32:173-219.
16. Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003;22:7369-75.
17. Ban N, Takahashi Y, Takayama T, et al. Transfection of glutathione S-transferase (GST)-π antisense complementary DNA increases the sensitivity of a colon cancer cell line to Adriamycin, cisplatin, melphalan, and etoposide. Cancer Res 1996;56:3577-82.
18. Ebert MN, Beyer-Sehlmeyer G, Liegibel UM, Kautenburger T, Becker TW, Pool-Zobel BL. Butyrate induces glutathione S-transferase in human colon cells and protects from genetic damage by 4-hydroxy-2-nonenal. Nutr Cancer 2001;41:156-64.
19. Pool-Zobel BL, Selvaraju V, Sauer J, et al. Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics. Carcinogenesis 2005;6:1064-76.
20. Litwack G, Ketterer B, Arias IM, Ligandin: a hepatic protein which binds steroids, bilirabin, carcinogens and a number of exogenous organic anions. Nature 1971;234:466-7.
21. Tipping E, Ketterer B, Koskelo P. The binding of porphyrins by ligandin. Biochem J 1978;169:509-16.
22. Adler V, Yin Z, Fuchs SY, et al. Regulation of JNK signaling by GSTp. EMBO J 1999;18:1321-34.
23. Ruscoe JE, Rosario LA, Wang T, et al. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 2001;298:339-45.
24. Elsby R, Kitteringham NR, Goldring CE, et al. Increased constitutive c-Jun N-terminal kinase signaling in mice lacking glutathione S-transferase π. J Biol Chem 2003;278:22243-9.
25. 2-induced cell death via coordinated regulation of stress kinases. Cancer Res 2000;60:4053-7.
26. Henderson CJ, Smith AG, Ure J, Brown K, Bacon EJ, Wolf CR. Increased skin tumorigenesis in mice lacking π class glutathione S-transferases. Proc Natl Acad Sci U S A 1998;95:5275-80.
27. Gate L, Majumdar RS, Lunk A, Tew KD. Influence of glutathione S-transferase TT and p53 expression on tumor frequency and spectrum in mice. Int J Cancer 2005;113:29-35.
28. You MJ, Castrillon DH, Bastian BC, et al. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci U S A 2002;99:1455-60.
29. Stewart SA, Hahn WC, O'Connor BF, et al. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A 2002;99:12606-11.
30. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2003-7.
31. Chan TA, Wang Z, Dang LH, Vogelstein B, Kinzler KW. Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation. Proc Natl Acad Sci U S A 2002;99:8265-70.
32. Cummins JM, Kohli M, Rago C, Kinzler KW, Vogelstein B, Bunz F. X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res 2004;64:3006-8.
33. Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C, Vogelstein B. Tumour suppression: disruption of HAUSP gene stabilizes p53. Nature 2004;428:1 p following 486.
34. Kohli M, Rago C, Lengauer C, Kinzler KW, Vogelstein B. Facile methods for generating human somatic cell gene knockouts using recombinant adeno-associated viruses. Nucleic Acids Res 2004;32:3-10.
35. Hirata R, Chamberlain J, Dong R, Russell DW. Targeted transgene insertion into human chromosomes by adeno-associated virus vectors. Nat Biotechnol 2002;20:735-8.
36. Samuels Y, Diaz LA, Jr., Schmidt-Kittler O, et al. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 2005;7:561-73.
37. 2 arrest after DNA damage. Science 1998;282:1497-501.
38. Kim JS, Lee C, Foxworth A, Waldman T. B-Raf is dispensable for K-Ras-mediated oncogenesis in human cancer cells. Cancer Res 2004;64:1932-7.
39. Shirasawa S, Funise M, Yokoyama N, Sasazuki T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 1993;260:85-8.
40. Sherley JL, Stadler PB, Stadler JS. A quantitative method for the analysis of mammalian cell proliferation in culture in terms of dividing and non-dividing cells. Cell Prolif 1995;28:137-44.
41. Jacobson MD, Raff MC. Programmed cell death and Bcl-2 protection in very low oxygen. Nature 1995;374:814-6.
42. Favata MF, Horiuchi KY, Manos EJ, et al. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 1998;273:18623-32.
43. 2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-α-driven colon cancer cells. J Biol Chem 2003;278:19861-9.
44. Dang LH, Bettegowda C, Huso DL, Kinzler KW, Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci U S A 2001;98:15155-60.
45. Dang LH, Bettegowda C, Agrawal N, et al. Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents. Cancer Biol Ther 2004;3:326-37.
46. Kraemer PM, Ray FA, Brothman AR, Bartholdi MF, Cram LS. Spontaneous immortalization rate of cultured Chinese hamster cells. J Natl Cancer Inst 1986;76:703-9.
47. Doerr R, Zvibel I, Chiuten D, D'Olimpio J, Reid LM. Clonal growth of tumors on tissue-specific biomatrices and correlation with organ site specificity of metastases. Cancer Res 1989;49:384-92.
48. Conzen SD, Cole CN. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts. Oncogene 1995;11:2295-302.
49. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996;85:27-37.
50. Dannenberg JH, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 2000;14:3051-64.
51. Blagosklonny MV. Oncogenic resistance to growth-limiting conditions. Nat Rev Cancer 2002;2:221-5.
52. Ravi R, Mookerjee B, Bhujwalla ZM, et al. Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α. Genes Dev 2000;14:34-44.
53. van den Bos C, Silverstetter S, Murphy M, Connolly T. p21(cip1) rescues human mesenchymal stem cells from apoptosis induced by low-density culture. Cell Tissue Res 1998;293:463-70.
54. van den Bos C, Mosca JD, Winkles J, Kerrigan L, Burgess WH, Marshak DR. Human mesenchymal stem cells respond to fibroblast growth factors. Hum Cell 1997;10:45-50.
55. Kops GJ, Medema RH, Glassford J, et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 2002;22:2025-36.
56. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8.
57. Long H, Han H, Yang B, Wang Z. Opposite cell density-dependence between spontaneous and oxidative stress-induced apoptosis in mouse fibroblast L-cells. Cell Physiol Biochem 2003;13:401-14.
58. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995;30:445-600.
59. Davis W, Jr., Ronai Z, Tew KD. Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 2001;296:1-6.
60. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51-88.
61. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999;49:91-102.
62. Del Rio D, Serafini M, Pellegrini N. Selected methodologies to assess oxidative/antioxidant status in vivo: a critical review. Nutr Metab Cardiovasc Dis 2002;12:343-51.
63. Wang T, Arifoglu P, Ronai Z, Tew KD. Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 2001;276:20999-1003.
64. Sebolt-Leopold JS, Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 2004;4:937-47.
65. Mansour SJ, Matten WT, Hermann AS, et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 1994;265:966-70.
66. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
67. Moorghen M, Cairns J, Forrester LM, et al. Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis 1991;12:13-7.
68. Esteller M, Corn PG, Urena JM, Gabrielson E, Baylin SB, Herman JG. Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 1998;58:4515-8.